14 Oct 2025
The 4th World Congress of Biopharm Industry Development (BID-2025) was held from September 24–26, 2025, at the Nanjiao Hotel in Shanghai, bringing together leading researchers and industry experts from across the globe. The conference served as a platform to exchange ideas on the latest advances in biotechnology, pharmaceuticals, and industrial applications.
Representing Xi’an Jiaotong-Liverpool University (XJTLU), Dr. Faez Iqbal Khan, Assistant Professor in the Department of Biological Sciences, took on a dual role as both session chair and invited speaker in Forum 3: Innovative Enzyme Preparation and Industrialization. In Session SEB 01: Emerging Technologies in Enzyme Discovery and Engineering, held on September 25, Dr. Khan chaired the discussions and delivered an invited talk titled “Decoding the Denaturation Pathway of Human Aurora Kinase B: Insights from Spectroscopy and Molecular Simulations.” His presentation highlighted the role of protein folding and unfolding dynamics in disease mechanisms and drug discovery, integrating both spectroscopic and computational approaches to uncover novel insights.
Faez Iqbal Khan: "It was an honor to present our work at BID-2025 and engage with global experts. Conferences like this inspire new collaborations and push the boundaries of biopharmaceutical research."
In addition, Dr. Magdalini Matziari, Associate Professor in the Department of Chemistry and Materials Science at XJTLU, presented her research on “Recent Advances on Phosphorus-Based Enzyme Inhibitors and Prodrugs.” Her talk focused on the design and therapeutic potential of phosphorus-based compounds, showcasing new directions in enzyme inhibitor development and prodrug strategies.
Magdalini Matziari: "Sharing our latest findings at an international platform like BID-2025 allows us to connect with peers, exchange ideas, and explore innovative approaches for drug discovery."
The active participation of the School of Science and XJTLU scholars at BID-2025 reflects the university’s growing contribution to the international biopharmaceutical research community. Professor John Moraros, Dean of the School of Science commented: “My warm congratulations to Dr. Faez Khan and Dr. Magdalini Matziari. By sharing their innovative research and engaging in global scientific dialogue, they help XJTLU continue to strengthen its reputation as a hub for cutting-edge science, interdisciplinary collaboration, and impactful discoveries.”
In addition to his contributions at BID-2025, Dr. Khan also recently served as an esteemed speaker and resource person at a hands-on workshop titled “Advanced Spectrophotometric Techniques: Protein Analysis for Disease Diagnostics and Drug Development”. The workshop, held on September 15–16, 2025, at the Department of Biochemistry, Jawaharlal Nehru Medical College (JNMC), Wardha, Maharashtra, India, was sponsored by DHR–ICMR. Dr. Khan conducted sessions on Computational Approaches in Enzyme Kinetics and Drug Interaction Studies as well as Advanced Data Analysis & Troubleshooting in Spectrophotometric Techniques & Drug-Protein Interactions. He is also an International Adjunct Faculty at Datta Meghe Institute of Higher Education & Research (DMIHER), further reflecting his active role in advancing global education and research capacity building. Most recently, he also chaired Technical Session S2 (Online) at the Third International Conference on Innovative Computing and Cutting-edge Technologies (ICICCT 2025), held on September 22–25, 2025, at the Holiday Inn Istanbul Old City Hotel, Istanbul, Turkey, where he evaluated five presentations by Master’s and PhD students.
Photos and content：Dr Faez Iqbal Khan
Review：Professor John Moraros
Translation：Luyao
14 Oct 2025